Millie
your market intelligence analyst
Search Results
367 results
Your search is now limited to «Partnerships and Collaborations» expert search.
Motley Fool 05/27/2020 14:55
The agreement also gives Gilead an equity position in the small-cap, clinical-stage biotech company.
More from Motley Fool:
Contract Pharma 05/27/2020 11:17
Merck and Ridgeback Biotherapeutics LP , a closely held biotechnology company, have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19 ...
More from Contract Pharma:
Reuters.com 05/27/2020 09:25
Merck KGaA:
More from Reuters.com:
Business Wire 05/27/2020 07:11
We are very pleased to build on Gilead’s growing presence in immuno-oncology with this important new strategic collaboration with Arcus,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences.
More from Business Wire:
Xconomy 05/27/2020 02:20
Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent COVID-19.
More from Xconomy:
Benzinga 05/26/2020 10:48
Merck's Partnership, M&A Deal For Coronavirus Vaccine Development Merck announced another collaboration to develop a SARS-CoV-2 vaccine candidate.
More from Benzinga:
The collaboration between Merck and IAVI represents an innovative partnership model and approach to utilize our joint capabilities in complementary and synergistic ways to address this difficult global health challenge,” Feinberg said in a statement.
More from TheHill.com: Healthcare Policy:
The master collaboration agreement also allows for expansion into additional disease indications and therapeutic categories.
More from Healthcare Sales & Marketing Network:
World Pharma News 05/26/2020 04:00
Sanofi remains committed to continuing our collaboration with Regeneron which remains an integral part of our overall strategy, and this decision was fully aligned with Regeneron," said Paul Hudson, Chief Executive Officer, Sanofi.
More from World Pharma News:
BioPharma-Reporter 05/25/2020 05:21
According to GSK, the partnership with Samsung Biologics has been agreed to provide it with additional capacity to manufacture its biologic therapies.
More from BioPharma-Reporter:
SynBioBeta 05/23/2020 07:31
Lilly will have the rights to develop and commercialize therapeutic products resulting from the collaboration.
More from SynBioBeta:
PR Newswire 05/21/2020 19:11
LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies.
More from PR Newswire:
GlobeNewswire 05/20/2020 07:05
CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today it has entered into a clinical trial collaboration with Merck (NYSE: MRK), known as MSD outside the United States and Canada, through a subsidiary, to evaluate the safety and efficacy of combining Surface’s SRF617, an investigational antibody therapy targeting CD39, with Merck’s KEYTRUDA ® (pembrolizumab), the first anti-PD-1 therapy approved in the United States.
More from GlobeNewswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications